

Toll-Free: (800) 266-7207  For Domestic | Intl: (404) 496-4049

  • Follow
  • Follow
  • Follow

Invest Now

  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Medical & Wellness Testing
  • Wound Care
  • Contact Us
  • News
  • Invest Now
  • Home
  • About Us
    • Our Tribe
    • Our Mission
    • Our Values
    • Our Future
  • Contact Us
  • Medical & Wellness Testing
  • Wound Care
  • News
  • Invest Now

Tribal Consortium Submits Post-Market Clinical Validation of Rampart™ DL Matrix to CMS as Government-to-Government Evidence

Nov 1, 2025 | News | 0 comments

The Tribal Biotechnology & Health Consortium today submitted the completed post-market clinical validation of Rampart™ DL Matrix (Q4347) to the Centers for Medicare & Medicaid Services and all seven Medicare Administrative Contractors as a formal sovereign...

A Statement on the Integrity of the Rampart™ Name and the Sovereign Authority of the Tribal Consortium

Oct 28, 2025 | News | 0 comments

A STATEMENT FROM THE OFFICE OF THE CEO Issued by Clear Health Pass Holdings, LLC, as Authorized Tribal Agent It has come to the attention of Clear Health Pass Holdings, in its capacity as Authorized Tribal Agent for the Tribal Biotechnology & Health Consortium,...

Tribal Consortium G2G Submission Posted Publicly on Regulations.gov

Sep 16, 2025 | News | 0 comments

The Tribal Biotechnology & Health Consortium’s full sovereign submission on the CY 2026 Medicare Physician Fee Schedule has been posted publicly on Regulations.gov, the federal government’s official rulemaking record platform, under Comment ID CMS-2025-0304-13291....

Tribal Consortium Files Comment on CY 2026 Medicare Physician Fee Schedule Proposed Rule (CMS-1832-P)

Sep 12, 2025 | News | 0 comments

The Tribal Biotechnology & Health Consortium today filed its formal sovereign comment on the proposed CY 2026 Medicare Physician Fee Schedule (CMS-1832-P), continuing a coordinated, multi-docket engagement with the Centers for Medicare & Medicaid Services. The...

Tribal Consortium Files Formal Comment on CY 2026 OPPS/ASC Proposed Rule (CMS-1834-P)

Sep 4, 2025 | News | 0 comments

The Tribal Biotechnology & Health Consortium today filed its formal comment on the proposed CY 2026 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System rule (CMS-1834-P), addressing the proposed treatment of skin substitute...

Clear Health Pass Appoints Dr. David Burke, MD, MA as Principal Investigator for Post-Market Clinical Validation of Rampart™ DL Matrix

Jul 28, 2025 | News | 0 comments

Clear Health Pass Holdings, on behalf of the Tribal Biotechnology & Health Consortium, today announced the appointment of David Burke, MD, MA as Principal Investigator for the post-market clinical validation of Rampart™ DL Matrix (Q4347). Dr. Burke is Department...
« Older Entries
Next Entries »

Recent Posts

  • Strengthen, Not Diminish: Tribal Nations Behind Rampart™ DL Matrix Stand for Sovereignty and Self-Determination
  • CMS Confirms Government-to-Government Receipt of Tribal Real-World Evidence Submission for Rampart™ DL Matrix
  • Tribal Consortium Commences Sovereign Enforcement Activity to Protect Tribal Authority Over the Rampart™ Product Line
  • CMS Federal Register Identifies Rampart™ DL Matrix as Tribally Owned in CY 2026 Medicare Physician Fee Schedule Policy Update
  • Tribal Consortium Issues Sovereign Notice to CMS Requesting Formal Recognition of Tribal Ownership of Q4347

Recent Comments

No comments to show.

ABOUT US

Clear Health Pass™ Clear Health Pass Holdings, LLC (“CHP”) serves as an authorized Tribal Agent for a multi-tribal economic development and sovereign innovation initiative, pursuant to written delegations issued by federally recognized Tribal economic development corporations organized under Section 16 / Section 17 of the Indian Reorganization Act (25 U.S.C. sections 5123-5124).

(800) 266-7207
(404) 496-4049

 

 

 

OUR TESTS

  • Clear Health Pass MDHeartPro
  • Clear Health Pass MDDiabeticPro
  • Clear Health Pass MDGeneticPro Women’s Health
  • Clear Health Pass MDAllergyPro
  • Clear Health Pass MDDrugPro
  • Clear Health Pass NIPT

OUR PARTNERS

Under Disclaimers & Regulatory Disclosures

 

    • No medical advice
    • Product regulatory status
    • Coverage and payment
    • Planned peptide and healthspan programs
    • Tribal relationship
    • Forward-looking statements
    • Securities disclosures
    • Intellectual property and trademarks
    • Third-party content, images and external links
    • Use of artificial intelligence
    • Website terms
    • Privacy Policy

 

© 2022-2025 Clear Health Pass Holdings, LLC. All rights reserved. Clear Health Pass, DrugPro, GeneticPro, DiabeticPro, and HeartPro are trademarks of Clear Health Pass Holdings, LLC. Unauthorized use of these trademarks is strictly prohibited.